journal article·2025-12-23

Pipemidic Acid–Based Organic Cocrystal Engineering for Targeted Infected Wound Healing

Zilin Wang, Yinghui Wang, Suchuan Zhang, Qiuxiang Yin, Li Xiao, Yuntian Xiao

Chemistry of Materials· Volume 37· Issue 24
Publisher page

Abstract

Organic cocrystal engineering has emerged as a powerful strategy for designing advanced multifunctional materials, especially in complicated biomedical applications that demand both adaptability and dynamic functionality. Among these, the treatment of infected wounds, characterized by bacterial colonization, oxidative stress, and impaired tissue regeneration, remains particularly challenging. However, to date, there have been few reports utilizing organic cocrystal engineering to address these multifactorial therapeutic needs in a sustainable manner. In this study, we introduce a novel supramolecular cocrystal framework that integrates the antibiotic pipemidic acid trihydrate with the naturally derived flavonoid kaempferol into a single lattice via supramolecular synthon design. The resulting supramolecular material forms an adaptive, multifunctional architecture capable of addressing the key obstacles in infected wound healing. It effectively inhibits bacterial proliferation, attenuates oxidative damage, and promotes cellular regeneration and tissue remodeling. Experimental results demonstrate that the self-assembled cocrystals not only accelerate wound closure but also reduce systemic toxicity compared to conventional single-component antimicrobial treatments. This work highlights the potential of organic cocrystal engineering as a sustainable and synergistic therapeutic platform for advanced biomedical applications, particularly in infection-responsive wound care.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Luminescence and Fluorescent Materials · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical Laboratory

Zigong First People’s Hospital

Guizhou Qiannan People’s Hospital (The First Affiliated Hospital of Qiannan Medical College for Nationalities)

School of Chemical Engineering and Technology, State Key Laboratory of Chemical Engineering

School of Plant Protection

Anhui Agricultural University

Anhui Province Engineering Laboratory for Green Pesticide Development and Application, School of Plant Protection

Funding

Health Commission of Guizhou Province · Zigong Science and Technology Program of China · Qiannan Medical College for Nationalities · Key Science and Technology Program Project of Zigong Academy of Integrated Traditional Chinese and Western Medicine, Zigong Science and Technology Bureau

References (74)

Show source-provided references
1. 10.1002/anie.19880089110.1002/anie.198800891 ↗
2. 10.1126/science.851158210.1126/science.8511582 ↗
3. 10.1039/C7CS00391A10.1039/C7CS00391A ↗
4. 10.1021/jacs.3c0617510.1021/jacs.3c06175 ↗
5. 10.1021/jacs.8b0243510.1021/jacs.8b02435 ↗
6. 10.1021/acs.accounts.9b0021110.1021/acs.accounts.9b00211 ↗
7. 10.1002/anie.20241618110.1002/anie.202416181 ↗
8. 10.1002/anie.19952311110.1002/anie.199523111 ↗
9. 10.1021/ja403264c10.1021/ja403264c ↗
10. 10.1039/D1CE01327K10.1039/D1CE01327K ↗
11. 10.1016/j.ajps.2018.04.00910.1016/j.ajps.2018.04.009 ↗
12. 10.1021/acs.cgd.2c0018410.1021/acs.cgd.2c00184 ↗
13. 10.1002/adma.20090053310.1002/adma.200900533 ↗
14. 10.1021/jacs.2c1142510.1021/jacs.2c11425 ↗
15. 10.1038/s41467-024-46869-610.1038/s41467-024-46869-6 ↗
16. 10.1039/D2GC02949A10.1039/D2GC02949A ↗
17. 10.1016/j.ccr.2024.21595310.1016/j.ccr.2024.215953 ↗
18. 10.1021/acs.jafc.3c0108410.1021/acs.jafc.3c01084 ↗
19. 10.1016/j.ajps.2020.06.00410.1016/j.ajps.2020.06.004 ↗
20. 10.1021/jacs.1c0767810.1021/jacs.1c07678 ↗
21. 10.1021/acs.accounts.0c0083010.1021/acs.accounts.0c00830 ↗
22. 10.1016/j.jconrel.2022.06.00310.1016/j.jconrel.2022.06.003 ↗
23. 10.1021/acs.molpharmaceut.3c0039810.1021/acs.molpharmaceut.3c00398 ↗
24. 10.1016/j.biopha.2022.11400410.1016/j.biopha.2022.114004 ↗
25. 10.1002/advs.20210515210.1002/advs.202105152 ↗
26. 10.1002/adfm.20191074810.1002/adfm.201910748 ↗
27. 10.1021/acs.molpharmaceut.0c0034610.1021/acs.molpharmaceut.0c00346 ↗
28. 10.1016/j.jconrel.2021.07.01710.1016/j.jconrel.2021.07.017 ↗
29. 10.1016/j.intimp.2024.11271310.1016/j.intimp.2024.112713 ↗
30. 10.1016/j.arcmed.2021.10.00710.1016/j.arcmed.2021.10.007 ↗
31. 10.1016/j.addr.2023.11476910.1016/j.addr.2023.114769 ↗
32. 10.1002/adhm.20140041810.1002/adhm.201400418 ↗
33. 10.1016/0305-4179(87)90045-310.1016/0305-4179(87)90045-3 ↗
34. 10.1021/acs.cgd.2c0150810.1021/acs.cgd.2c01508 ↗
35. 10.1039/D1NJ03314J10.1039/D1NJ03314J ↗
36. 10.1021/jacs.9b0663410.1021/jacs.9b06634 ↗
37. 10.1002/ange.20210797810.1002/ange.202107978 ↗
38. 10.1021/acsami.4c0820610.1021/acsami.4c08206 ↗
39. 10.1107/S010827018609126610.1107/S0108270186091266 ↗
40. 10.1039/D0CE01533D10.1039/D0CE01533D ↗
41. 10.1007/s13738-023-02905-810.1007/s13738-023-02905-8 ↗
42. 10.1107/S160053681101106810.1107/S1600536811011068 ↗
43. 10.1039/c2ce26055g10.1039/c2ce26055g ↗
44. 10.1039/D1FD00081K10.1039/D1FD00081K ↗
45. 10.1021/acs.cgd.3c0018310.1021/acs.cgd.3c00183 ↗
46. 10.1021/acs.cgd.1c0048010.1021/acs.cgd.1c00480 ↗
47. 10.1016/j.ccr.2024.21603510.1016/j.ccr.2024.216035 ↗
48. Bryskier A. · Antimicrob. Agents · 2005 · 1
49. 10.1002/jcc.2681210.1002/jcc.26812 ↗
50. 10.1016/j.cej.2023.14375710.1016/j.cej.2023.143757 ↗
51. 10.1016/j.cej.2023.14603710.1016/j.cej.2023.146037 ↗
52. 10.1021/ja910608m10.1021/ja910608m ↗
53. 10.1002/adma.20230333110.1002/adma.202303331 ↗
54. 10.1039/C8CS00508G10.1039/C8CS00508G ↗
55. 10.3390/ijms23231505410.3390/ijms232315054 ↗
56. 10.1099/jmm.0.00047510.1099/jmm.0.000475 ↗
57. 10.1016/j.ica.2021.12047410.1016/j.ica.2021.120474 ↗
58. 10.1002/adfm.20221399310.1002/adfm.202213993 ↗
59. 10.1038/cr.2013.7510.1038/cr.2013.75 ↗
60. 10.1038/nature0997310.1038/nature09973 ↗
61. 10.1016/j.cej.2023.14609210.1016/j.cej.2023.146092 ↗
62. 10.1186/s13287-019-1152-x10.1186/s13287-019-1152-x ↗
63. 10.1016/j.bioactmat.2022.11.02310.1016/j.bioactmat.2022.11.023 ↗
64. 10.1002/smll.20190032210.1002/smll.201900322 ↗
65. 10.1016/j.matbio.2018.06.00410.1016/j.matbio.2018.06.004 ↗
66. 10.1097/MOH.000000000000023910.1097/MOH.0000000000000239 ↗
67. 10.1038/aps.2017.16110.1038/aps.2017.161 ↗
68. 10.3390/ijms2503142510.3390/ijms25031425 ↗
69. 10.31083/j.fbl290415310.31083/j.fbl2904153 ↗
70. 10.1002/adhm.20200087210.1002/adhm.202000872 ↗
71. 10.1016/j.jpba.2007.10.03010.1016/j.jpba.2007.10.030 ↗
72. 10.1155/2014/30475710.1155/2014/304757 ↗
73. 10.1002/jcc.2288510.1002/jcc.22885 ↗
74. 10.1016/j.mtcomm.2023.10768810.1016/j.mtcomm.2023.107688 ↗